Steve Littlejohn is a 40-year communications veteran with more than 25 years of experience in healthcare. Currently, Steve undertakes select consulting assignments while growing a portfolio of volunteer initiatives.
Previously, Steve served as Vice President, Communications and Public Affairs, for Mallinckrodt where he successfully resolved U.S. and E.U. nuclear medicine issues for the company.
Prior to Mallinckrodt, Steve served as Vice President, Public Affairs, at Express Scripts, where he implemented an award-winning generic drug campaign saving millions and led creation of the SOSRx drug safety coalition with the National Consumers League.
Earlier, at the global communications firm FleishmanHillard, he built a million-dollar healthcare services practice, led the St. Louis health and environment group, and developed a patient safety crisis communications specialty. Previously, he held positions at DuPont, Gulf Oil, and Monsanto.
Steve played a key role in the formation of the National Patient Safety Foundation (NPSF), serving ex officio on the inaugural board as chair of the communications committee. More recently, he served on the foundation’s Board of Advisors, where he co-chaired the subcommittee that drafted the NPSF call to action on patient safety as a public health issue.
Currently, Steve serves on the Certification Board for Professionals in Patient Safety, the Institute for Healthcare Improvement (IHI) Patient Safety Advisory Committee, the IHI/NPSF National Steering Committee for Patient Safety (ex officio) and the IHI/NPSF Daisy Award Review Panel. He is also active in the fight against antimicrobial resistance, in memory of his daughter, Meredith, who died at 19 of a hospital acquired antimicrobial resistant infection after battling acute myeloid leukemia for a year, nine months of which in the hospital.
Steve earned a B.A. in history from Harvard University, an M.A. in history from Cambridge University and an M. B. A. from the University of Pittsburgh. He is the author of “Competition and Cooperation: New Trends in Corporate Public Issue Identification and Resolution” (California Management Review), “Patient Safety: A Public Health Crisis for a Nation of Patients” (STAT), “Medical Error and Patient Safety: Communicating with the Media,” (The Patient Safety Handbook), and a co-author of “Innovation on Trial: Punitive Damages Versus New Products” (Science).
For more, visit Steve’s LinkedIn page.